Fujita, Shiro

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor: Comparison between T790M mutation‐positive and mutation‐negative populations

Hata, A., Katakami, N., Yoshioka, H., Takeshita, J., Tanaka, K., Nanjo, S., Fujita, S., Kaji, R., Imai, Y., Monden, K., et al. (2013) · Cancer

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 178

Clinical experience with lingualplasty as part of the treatment of severe obstructive sleep apnea

Woodson, B. T., & Fujita, S. (1992) · Otolaryngology–Head and Neck Surgery

Obstructive Sleep Apnea ResearchNasal Surgery and Airway Studies

Cited by 136

Good Clinical Response to Gefitinib in a Non-small Cell Lung Cancer Patient Harboring a Rare Somatic Epidermal Growth Factor Gene Point Mutation; Codon 768 AGC > ATC in Exon 20 (S768I)

Masago, K., Fujita, S., Irisa, K., Kim, Y. H., Ichikawa, M., Mio, T., & Mishima, M. (2010) · Japanese Journal of Clinical Oncology

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 51